Immune to Cancer: The CRI Blog
-
Introducing Dr. Alicia Zhou: A New Chapter in Leadership at the Cancer Research Institute
The Cancer Research Institute (CRI) is excited to announce a transformative moment in its history with the… -
Sarcoma Awareness Month: Tackling Chordoma with Dr. Cassian Yee
CRI-Chordoma Foundation CLIP Investigator Dr. Cassian Yee is exploring how to design cell therapies for patients with…
-
CRI Speaks with 2021 Lloyd J. Old Award Recipient Dr. Ton Schumacher
Dr. Ton Schumacher, 2021 Lloyd J. Old Award recipient, discusses his career accomplishments and the future of…
-
What to Expect in Cancer Immunotherapy in 2021: COVID-19, Biomarkers, and Clinical Trial Design
Dr. Kunle Odunsi shares his thoughts on what lies ahead for the field of cancer immunotherapy.
-
Las mujeres que erigieron el CRI y promovieron la inmunoterapia como tratamiento del cáncer
CRI highlights some of the many women who are and have been integral to our organization and…
-
CRI Scientific Leadership in Cancer and COVID-19
Members of the CRI Scientific Advisory Council are providing their immunology expertise and sharing lessons from cancer…
-
Dr. Robert Schreiber and Interferon Gamma
By redefining our understanding of the relationship between cancer and the immune system, Dr. Robert Schreiber has…
-
Dr. James P. Allison, CRI Scientific Director, Awarded 2018 Nobel Prize along with Dr. Tasuku Honjo
Dr. Allison’s discoveries and determination led to the development of the first FDA-approved checkpoint immunotherapy
-
Previewing the 2018 Rational Combinations 360 Conference
The third installment of the Rational Combinations 360 conference, which will be held in Philadelphia September 13-14,…